Investigations of Interferon-Lambda for the Treatment of Cancer

Publisher： Karger

E-ISSN： 1662-8128|7|3|243-250

ISSN： 1662-811x

Source： Journal of Innate Immunity, Vol.7, Iss.3, 2015-02, pp. : 243-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Correlation between Hepatitis C Core Antigen and Hepatitis C Virus RNA Levels with Respect to Human Immunodeficiency Virus Status, Hepatitis C Virus Genotype and Interferon-Lambda-4 Polymorphism

By  

Intervirology, Vol. 58, Iss. 2, 2015-02 ,pp. : 73-79

Karger

Access to resources Recommend Favorite

Phase 2 Trial of Interferon-Beta as Second-Line Treatment of Ovarian Cancer, Fallopian Tube Cancer, or Primary Carcinoma of the Peritoneum

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 343-346

Karger

Access to resources Recommend Favorite

Fluorouracil and Leucovorin with or without Interferon Alfa-2a as Adjuvant Treatment, in Patients with High-Risk Colon Cancer

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 227-236

Karger

Access to resources Recommend Favorite

Psychiatric Side Effects of Interferon Treatment

By  

Current Drug Safety, Vol. 1, Iss. 2, 2006-05 ,pp. : 143-150

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1377-1378

John Wiley & Sons Inc

Access to resources Recommend Favorite